CIBC World Markets’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,669
Closed -$467K 733
2024
Q1
$467K Buy
+19,669
New +$437K ﹤0.01% 727
2021
Q2
Sell
-33,500
Closed -$757K 720
2021
Q1
$757K Buy
+33,500
New +$757K ﹤0.01% 683
2018
Q1
Sell
-239,100
Closed -$7.27M 668
2017
Q4
$7.27M Buy
+239,100
New +$6.36M 0.05% 267
2017
Q2
Sell
-164,000
Closed -$3.55M 651
2017
Q1
$3.55M Buy
+164,000
New +$3.34M 0.03% 283

Other funds holding EXEL

CIBC World Markets's EXEL Position: Q2 2024 in Review

CIBC World Markets sold out of Exelixis (EXEL) in Q2 2024, closing a stake of 19,669 shares — an estimated $467K sold.

CIBC World Markets first reported a position in EXEL in Q1 2017 and held it in 4 quarters. The position peaked at $7.27M in Q4 2017. 413 funds tracked by Wall St. Rank hold EXEL as of Q2 2024.

  • CIBC World Markets reported no remaining Exelixis position as of Q2 2024 after selling out during the quarter.
  • CIBC World Markets sold 19,669 Exelixis shares in Q2 2024, an estimated $467K.
  • CIBC World Markets first reported a position in Exelixis in Q1 2017 and held it in 4 quarters.
  • CIBC World Markets's Exelixis position peaked at $7.27M in Q4 2017.
  • 413 funds tracked by Wall St. Rank held Exelixis as of Q2 2024.

Based on CIBC World Markets's 13F filing for Q2 2024, filed 12 Aug 2024.